Abstract
Inhalation of silica and asbestos fibres by humans can lead to fibrosis of the lung and cancer. Different mechanistic approaches, including oxidative stress, are used for prophylactic and therapeutic interventions to attenuate the fibrogenic and carcinogenic effects of these particles. Thus far, most of these therapeutic interventions have been only partly successful. A review of the mechanisms which are thought to be involved in mineral particle-induced toxicity and the relevant therapeutic interventions used to date to counteract these mechanisms, will help formulate better prophylactic and treatment intervention strategies in the future.
Similar content being viewed by others
References
Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A: Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst 67: 965–975, 1981
Hochelia MF Jr: Surface chemistry, structure, and reactivity of hazardous mineral dusts. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, pp 275–308
Nash T, Allison AC, Harington JS: Physico-chemical properties of silica in relation to its toxicity. Nature 210: 259–261, 1966
Nolan RP, Langer AM, Harington JS, Oster G, Selikoff IJ: Quartz hemolysis as related to its surface functionalities. Environ Res 26: 503–520, 1981
Fubini B, Bolis V, Cavenago A, Volante M: Physico-chemical properties of crystalline silica dusts and their possible implication in various biological responses. Scan J Work Environ Health 21(suppl 2): 9–14, 1995
Weitzman SA, Graceffa P: Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 228: 373–376, 1984
Eberhardt MK, Romàn-Franco AA, Quiles MR: Asbestos-induced decomposition of hydrogen peroxide. Environ Res 37: 287–292, 1985
Gulumian M, van Wyk JA: Hydroxyl radical production in the presence of fibres by a Fenton-type reaction. Chem-Biol Interact 62: 89–97, 1987
Vallyathan V, Mega J F, Shi X, Dalal NS: Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am J Resp Cell Mol Biol 6: 404–413, 1992
Hatch GE, Gardner DE, Menzel DB: Stimulation of oxidant production in alveolar macrophages by pollutant and latex particles. Environ Res 23: 121–136, 1980
Berg I, Schlüter T, Gercken G: Increase of bovine alveolar macrophage superoxide anion and hydrogen peroxide release by dusts of different origin. J Toxicol Environ Health 39: 341–354, 1993
Ishizaki T, Yano E, Urano N, Evans PH: Crocidolite-induced reactive oxygen metabolites generation from human polymorphonuclear leukocytes. Environ Res 66: 208–216, 1994
Hansen K, Mossman BT: Generation of superoxide (O2 -·) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 47: 1681–1686, 1987
Dubois CM, Bissonnette E, Rola-Pleszczynski M: Asbestos fibres and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Resp Dis 139: 1257–1264, 1989
Heaney PJ, Banfield JA: Structure and chemistry of silica, metal oxides, and phosphates. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, 185–233.
Veblen DR, Wylie AG: Mineralogy of amphiboles and 1:1 layer silicates. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, 61–137
Hearne GR, Kolk B, Pollak H, van Wyk JA, Gulumian M: Bulk and surface modifications in detoxified crocidolite. J Inorg Biochem 50: 145–156, 1993
Brown GM, Donaldson K, Brown DM: Bronchoalveolar leukocyte response in experimental silicosis: Modulation by a soluble aluminum compound. Toxicol Appl Pharmacol 101: 95–105, 1989
Dufresne A, Sébastien P, Michaud D, Perrault G, Bégin R: Influence of aluminum treatments on pulmonary retention of quartz in sheep silicosis. Exp Lung Res 20: 157–168, 1994
Bégin R, Massé S, Dufresne A: Further information on aluminium inhalation in silicosis. Occup Environ Med 52: 778–780, 1995
Schlipköter HW, Brockhaus A: The action of polyvinyl pyridine on experimental silicosis. Dtsch Med Wochenschr 85: 920–923, 1960
Kaw JL, Beck EC, Bruck J: Studies of quartz cytotoxicity on peritoneal macrophages of guinea pigs pretreated with polyvinyl pyridine N-oxide. Environ Res 9: 313–320, 1975
Von Behren LA, Chudhary S, Rabinovich E, Shu MO, Tewari RP: Protective effect of poly-2–vinyl pyridine-N-oxide on susceptibility of silica-treated mice to experimental histoplasmosis. Infect Immun 42: 818–823, 1983
Jinduo Z, Jundge L, Guizhi L: Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis. Zentralbl Bakteriol Hyg I Abt Orig B 178: 259–262, 1983
Davis JMG: The effects of polyvinylpyridine-N-oxide (P204) on the cytopathogenic action of chrysotile asbestos in vivo and in vitro. Br J Exp Pathol 53: 652–658, 1972
Schlipköter HW, Brockhaus A: Die Hemmung der experimentallen Silikose durch subcutane Verabreichung von poly-vinylpyridine-N-oxyd. Klin Wochenschr 39: 1182–1189, 1961
Marchisio MA, Comolli R: Studio metabolico e morfologico deil'attività liticoprotettiva delia poli-2–vinil-piridina-N-ossido su macrofagi peritoneali trattati con silice. Med Lav 55: 401–410, 1964
Mao Y, Lambert ND, Knapton AD, Shi X, Saffiotti U: Protective effects of silanol group binding agents on quartz toxicity to rat lung alveolar cells. Appl Occup Environ Hyg 10: 1132–1137, 1995
Gulumian M, van Wyk A: Free radical scavenging properties of polyvinylpyridine N-oxide: A possible mechanism for its action in pneumoconiosis. 78: 124–128, 1987.
Emerson RJ, Davis GS: Effect of alveolar lining material-coated silica on rat alveolar macrophages. Environ Health Perspect 51: 81–84, 1983
Wallace WE, Vallyathan V, Keane MJ, Robinson V: In vitro biologic toxicity of native and surface modified silica and kaolin. J Toxicol Environ Health 16: 415–424, 1985
Schimmelpfeng J, Drosselmeyer E, Hofheinz V, Seidel A: Influence of surfactant components and exposure geometry on the effects of quartz and asbestos on alveolar macrophages. Environ Health Perspect 97: 225–231, 1992
Jabbour AJ, Holian A, Scheule RK: Lung lining fluid modification of asbestos bioactivity for the alveolar macrophage. Toxicol Appl Pharmacol 110: 283–294, 1991
Antonini JM, Reasor MJ: Effect of short-term exogenous pulmonary surfactant treatment on acute lung damage associated with the intratracheal instillation of silica. J Toxicol Environ Health 43: 85–101, 1994
Antonini JM, McCloud CM, Reasor MJ: Acute silica toxicity: Attenuation by amiodarone-induced pulmonary phospholipidosis. Environ Health Perspect 102: 372–378, 1994
Blake TL, DiMatteo M, Antonini JM, McCloud CM, Reasor MJ: Subchronic pulmonary inflammation and fibrosis induced by silica in rats are attenuated by amiodarone. Exp Lung Res 22: 113–131, 1996
Brown RC, Carthew P, Hoskins JA, Sara E, Simpson CF: Surface modification can affect the carcinogenicity of asbestos. Carcinogenesis 11: 1883–1885, 1990
Vallyathan V, Kang JH, Van Dyke K, Dalal NS, Castranova V: Response of alveolar macrophages to in vitro exposure to freshly fractured versus aged silica dust: The ability of Prosil 28, an organosilane material, to coat silica and reduce its biological reactivity. 33: 303–315, 1991
Wiessner JH, Mandel NS, Sohnle PG, Hasegawa A, Mandel GS: The effect of chemical modification of quartz surfaces on particulateinduced pulmonary inflammation and fibrosis in the mouse. Am Rev Resp Dis 141: 111–116, 1990
Evans PH, Brown RC, Poole A: Modification of the in vitro activities of amosite asbestos by surface derivatization. J Toxicol Environ Health 11: 535–543, 1983
Zalma R, Bonneau L, Guignard J, Pezerat H, Jaurand MC: Formation of oxy radicals by oxygen reduction arising from the surface activity of asbestos. Can J Chem 65: 2338–2341, 1987
Zalma R, Bonneau L, Guignard J, Pezerat H: Production of hydroxyl radicals by iron solid compounds. Toxic Environ Chem 13: 171–187, 1987
Zalma R, Guignard J, Pezerat H: Production of radicals arising from surface activity of fibrous minerals. In: B.T. Mossman, R.O. Bégin (eds). Effects of Mineral Dusts on Cells. NATO ASI Series, Vol. H30. Springer-Verlag, Berlin Heidelberg, 1989, pp 257–264.
Gulumian M, van Wyk JA: Lipid peroxidation by mineral dusts and fibres: ESR studies of oxygen uptake during peroxidation of lipids in multilamellar liposomes. S Afr J Sci 87: 591–593, 1991
Yamano Y, Kagawa J, Hanoka T, Takahashi T, Kasai H, Tsugane S, Watanabe S: Oxidative DNA damage induced by silica in vivo. Environ Res 69: 102–107, 1995
Jackson JH, Schraufstatter IU, Hyslop PA, Vosbeck K, Sauerheber R, Weitzman SA, Cochrane CG: Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J Clin Invest 80: 1090–1095, 1987
Hardy JA, Aust AE: The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16: 319–325, 1995
Kupchan SM, Atland HW: Requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds. J Med Chem 16: 913–917, 1973
Yu XF, Zou CQ, Lim MB: Observation of the effect of tetrandrine on experimental silicosis of rats. Ecotoxicol Environ Saf 7: 306–312, 1983
Li Q, Xu Y, Zhow Z, Chen X, Huang X, Chen S, Zhun C: The therapeutic effect of tetrandrine on silicosis. Chin J Tuberc Resp Diseases 4: 321–328, 1981
Castranova V, Kang J-H, Ma JKH, Mo C-G, Malanga CJ, Moore MD, Schwegler-Berry D, Ma JYC: Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: Correlation between binding affinity, inhibitory potency, and antifibrotic potential. Toxicol Appl Pharmacol 108: 242–252, 1991
Ma JKH, Mo C-G, Malanga CJ, Ma JYC, Castranova V: Binding of bisbenzylisoquinoline alkaloids to phosphatidylcholine vesicles and alveolar macrophages: Relationship between binding affinity and antifibrotic potential of these drugs. Exp Lung Res 17: 1061–1077, 1991
Castranova V, Kang JH, Moore MD, Pailes WH, Frazer DG, Schwegler-Berry D: Inhibition of stimulant-induced activation of phagocytic cells with tetrandrine. J Leuk Biol 50: 412–422, 1991
Liu L, Chen N, Cai G, Li Z, Yang J, Li Y: Studies on the effects of tetrandrine on microtubules. I. Biochemical observation and electron microscopy. Ecotoxicol Environ Safety 15: 142–148, 1988
Chen N, Liu L, Cai G, Yang J, Li Y: Studies on the effects of tetrandrine on microtubules. II. Observations with immunofluorescence techniques. Ecotoxicol Environ Saf 15: 149–152, 1988
Cao ZF: Scavenging effect of tetrandrine on active oxygen radicals. Planta Med 62: 413–414, 1996
Shi X, Mao Y, Saffiotti U, Wang L, Rojanasakul Y, Leonard SS, Vallyathan V: Antioxidant activity of tetrandrine and its inhibition of quartz-induced lipid peroxidation. Toxicol Environ Health 46: 233–248, 1995
Pang L, Hoult RS: Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid accompanied by an overproduction of prostaglandins. Biochem Pharmacol 53: 773–782, 1997
He Y, Liu B, Miao Q, Zhang Q: The effects of tetrandrine on collagen gene expression in SiO2-induced experimental silicosis. The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles. Abstract 106. September 15–18, 1996
Khan SG, Shahid A, Rahman Q: Protective role of ascorbic acid against asbestos induced toxicity in rat lung. Drug Chem Toxicol 13: 249–256, 1990
Mironova GE: Effect of ascorbic acid on development of pneumofibrosis caused by silicon dioxide. Vopr Med Khim 37: 84–86, 1991
Holts G, Bresnick E: Ascorbic acid inhibits the squamous metaplasia that results from treatment of tracheal explants with asbestos or benzo[a]pyrene-coated asbestos. Cancer Lett 42: 23–28, 1988
Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM: Novel 21–aminosteroids as potent inhibitors of irondependent lipid peroxidation. J Biol Chem 262: 10438–10440, 1987
Antonini JM, van Dyke K, DiMatteo M, Reasor MJ: Attenuation of acute inflammatory effects of silica in rat lung by 21–aminosteroid, U74389G. Inflammation 19: 9–21, 1995
Maksimenko AV, Grigor'eva EL, Bezrukavnikova LM, Petrov AD, Tishchenko EG, Arkhipova OG, Torchilin VP: Antifibrotic effect of dextran aldehyde-modified superoxide dismutase in experimental silicosis. Byull Eksp Biol Med 112: 265–267, 1991
Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D, Mickey R, Vacek P, Kagan E: Inhibition of lung injury, inflammation and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Resp Dis 141: 1266–1271, 1990
Mossman BT, Surinrut P, Brinton BT, Marsh P, Heintz NH, Lindau-Shepard B, Shaffer JB: Transfection of a manganese-containing superoxide dismutase gene into hamster tracheal epithelial cells ameliorates asbestos-mediated cytotoxicity. Free Rad Biol Med 21: 125–131, 1996
Goss GD, McBurney MW: Physiological and clinical aspects of vitamin A and its metabolites. Crit Rev Clin Lab Sci 29: 185–215, 1992
Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE, Watson RR: The effects of 13–cis-retinoic acid and β-carotene on cellular immunity in humans. Cancer (Phila) 67: 1556–1560, 1991
Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, Balmes J, Cherniack MG, Cullen MR, Glass A, Keogh J, Meyskens F Jr, Valanis B, Williams J Jr: The β-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Res (suppl)54: 2038s–2043s, 1994
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Hammar S: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 334: 1150–1155, 1996
Chuwers P, Barnhart S, Blanc P, Brodkin CA, Cullen M, Kelly T, Keogh J, Omenn G, Williams J, Balmes JR: The protective effect of β-carotene and retinol on ventilatory function in an asbestos-exposed cohort. Am J Resp Crit Care Med 155: 1066–1071, 1997
Schiffman MH, Pickle LW, Fontham E, Zahm SH, Falk R, Mele J, Correa P, Fraumeni JF Jr: Case-control study of diet and mesothelioma in Louisiana. Cancer Res 48: 2911–2915, 1988
Rees DJ: A case-control study of mesothelioma in South Africa. A thesis submitted to the Faculty of Medicine, University of Cape Town, for the degree of Doctor of Philosophy. Johannesburg, 1995
Sahu AP: Chronic lung injury due to mineral particles: Possible prevention of their fibrogenic potential. The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles. Abstract 107. September 15–18, 1996
Hoffman H, Hatherill JR, Crowley J, Harada H, Yonemaru M, Zheng H, Ishizaka A, Raffin TA: Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs. Am Rev Resp Dis 143: 289–293, 1991
O'Neil CA, Giri SN, Wang Q, Perricone MA, Hyde DM: Effects of dibutyryl cyclic adenosine monophosphate on bleomycin-induced lung toxicity in hamsters. J Appl Toxicol 12: 97–111, 1992
Kennedy TP, Michael JR, Hoidal JR, Hasty D, Sciuto AM, Hopkins C, Lazar R, Bysani GK, Tolley E, Gurtner GH: Dibutyryl cAMP, aminophylline, and β-adrenergic agonists protect against pulmonary edema caused by phosgene. J Appl Physiol 67: 2542–2552, 1989
Riva CM, Morganroth ML, Ljungman AG, Schoeneich SO, Marks RM, Todd RF III, Ward PA, Boxer LA: Iloprost inhibits neutrophilinduced lung injury and neutrophil adherence to endothelial monolayers. Am J Resp Cell Mol Biol 3: 301–309, 1990
Ochoa L, Waypa G, Mahoney JR Jr, Rodriguez L, Minnear FR: Contrasting effects of hypochlorous acid and hydrogen peroxide on endothelial permeability. Prevention with cAMP drugs. Am J Crit Care Med 156: 1247–1255, 1997
Israbian VA, Weitzman SA, Kamp DW: Dibutyryl cAMP attenuates asbestos-induced pulmonary epithelial cell cytotoxicity and decline in ATP levels. Am J Physiol 267: L518–L525, 1994
Morosova KI, Aronova GV, Katsnelson BA, Velichkovski BT, Genkin AM, Einichnykh LN, Privalova LI: On the defensive action of glutamate against the cytotoxicity and fibrogenicity of quartz dust. Br J Indust Med 39: 244–252, 1982
Morosova KI, Katsnelson BA, Rotenberg YS, Belobragina GV: A further experimental study of the antisilicotic effect of glutamate. Br J Indust Med 41: 518–525, 1984
Flowers ES: Metal-Micelle asbestos and treatment of asbestos and other mineral silicates to reduce their harmful properties: US Patent 4,328,197; May 4; assigned to Flow General Inc. McLean, Va., 1982
Gulumian M, van Wyk JA, Kolk B: Detoxified crocidolite exhibits reduced radical generation which could explain its lower toxicity: ESR and Mössbauer studies. In: BT Mossman, RO Bégin (eds). Effects of Mineral Dusts on Cells. NATO ASI Series, Vol. H30. Springer-Verlag, Berlin, Heidelberg, 1989, pp 197–204
Gulumian M, van Wyk JA, Hearne GR, Kolk B, Pollak H: ESR and Mössbauer studies on detoxified crocidolite: Mechanism of reduced toxicity. J Inorg Biochem 50: 133–143, 1993
Hahon N, Vallyathan V, Booth JA, Sepulveda MJ: In vitro biologic response to native and surface-modified asbestos. Environ Res 39: 345–355, 1986
Gulumian, M, Nkosibomvu ZL, Channa K, Pollak H: Can microwave radiation at high temperatures reduce the toxicity of fibrous crocidolite asbestos? Environ Health Perspect 105(suppl 5): 1041–1044, 1997
Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA: Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: Role of iron-catalyzed free radicals. Am J Physiol 268: L471–L480, 1995
Kamp DW, Israbian VA, Yeidandi AV, Panos RJ, Graceffa P, Weitzman SA: Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos. Toxicol Pathol 23: 689–695, 1995
Weitzman SA, Weitberg AB: Asbestos-catalysed lipid peroxidation and its inhibition by desferroxamine. Biochem J 225: 259–262, 1985
Weitzman SA, Chester JF, Graceffa P: Binding of deferoxamine to asbestos fibers in vitro and in vivo. Carcinogenesis 9: 1643–1645, 1988
Chao C-C, Aust AE: Effect of long-term removal of iron from asbestos by desferrioxamine B on subsequent mobilization by other chelators and induction of DNA single-strand breaks. Archiv Biochem Biophys 308: 64–69, 1994
Driscoll KE, Maurer JK: Cytokine and growth factor release by alveolar macrophages: Potential biomarkers of pulmonary toxicity. Toxicol Pathol 19: 398–405, 1991
Williams AO, Saffiotti U: Growth factors and gene expression in silica-induced fibrogenesis and carcinogenesis. Appl Occup Environ Hyg 10: 1089–1098, 1995
Piguet PF, Vesin C, Grau GE, Thompson RC: Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5: 57–61, 1993
Henderson RF, Harkema JR, Hotchkiss JA, Boehme DS: Effect of blood leukocyte depletion on the inflammatory response of the lung to quartz. Toxicol Appl Pharmacol 109: 127–136, 1991
DiMatteo M, Reasor MJ: Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol Appl Pharmacol 142: 411–421, 1997
Liu K, Situ R, Liao J: The effect of anti basic fibroblast growth factor on the development of experimental silicosis bacillus. Chung Hua Chieh Ho Ho Hsi Tsa Chih (CYH) 18: 351–353, 1995
Piguet PF, Rosen H, Vesin C, Grau GE: Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Resp Dis 147: 435–441, 1993
Rosmanith J, Breining H: The reduction of quartz effect by natural anhydrite in animal experiment. Wiss Umwelt 182–188, 1988
Plastinina IuV, Privalova LI, Tereshin Slu, Katsnel'son BA, Kislitsina NS: Precutaneous effects of iodine inhibit the development of experimental silicosis. Med Tr Prom Ekol 7: 16–20, 1996
Li H, Wu Z, Zeng X, Liu S, Zheng Z, Zeng L, Duanmu B, Ke F, Yang H, Qing Y: Pathological observation of experimental asbestosis treated by hydroxypiperquin phosphate in dogs. Huaxi Yike Daxue Xuebao 22: 181–184, 1991
Soodaeva SK, Ostrakhovich EA, Velichkovskii BT: Changes in the blood serum antioxidant system and peroxidation of lipids during exposure to asbestos. Byull Eksp Biol Med 118: 145–147, 1994
Yu L, Zhou CQ, Li YR, Qu L, Xing KJ, Du QC: A biochemical study on combined treatment of experimental silicosis with tetrandrine-PVNO and tetrandrine-QOHP in rats. Biomed Environ Sci 8: 265–268, 1995
Muhle H, Bellmann B, Pott F: Durability of various mineral fibres in rat lungs. In: R.C. Brown, J.A. Hoskins, N.F. Johnson (eds). Mechanisms in Fibre Carcinogenesis. NATO ASI Series A. Life Sciences 223, Plenum Press, New York, 1991, pp 181–187
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gulumian, M. The role of oxidative stress in diseases caused by mineral dusts and fibres: Current status and future of prophylaxis and treatment. Mol Cell Biochem 196, 69–77 (1999). https://doi.org/10.1023/A:1006918212866
Issue Date:
DOI: https://doi.org/10.1023/A:1006918212866